Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 1 Serum levels of IL-6 and anti-collagen Ab do not differ between CD97 mAb-treated and control groups (mean ± SEM)

From: CD97 neutralisation increases resistance to collagen-induced arthritis in mice

  NaCl cIga CD97 mAba
IL-6 (pg/ml)    
   Treatment started on day 21 28 ± 4 28 ± 4 20 ± 1
   Treatment started on day 35 24 ± 3 29 ± 5 23 ± 3
Anti-collagen Ab (μg/ml)    
   Treatment started on day 21 2,186 ± 592 1,539 ± 499 1,001 ± 199
   Treatment started on day 35 494 ± 143 600 ± 137 578 ± 135
  1. aMice were treated with 0.5 mg. Ab, antibody; cIg, control immunoglobulin; IL-6, interleukin-6; mAb, monoclonal antibody; SEM, standard error of the mean.